These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6328823)

  • 1. Urinary and nephrogenous cyclic AMP and renal phosphate handling in normal subjects and patients with parathyroid dysfunction.
    Khoury S; Tucci JR
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):219-26. PubMed ID: 6328823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.
    Broadus AE; Mahaffey JE; Bartter FC; Neer RM
    J Clin Invest; 1977 Oct; 60(4):771-83. PubMed ID: 197123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary cyclic AMP and nephrogenous cyclic AMP in the diagnosis of parathyroid disorders (author's transl)].
    Sohn HW
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):804-17. PubMed ID: 6250920
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
    Broadus AE; Deftos LJ; Bartter FC
    J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tubular maximum for magnesium in normal, hyperparathyroid, and hypoparathyroid man.
    Rude RK; Bethune JE; Singer FR
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1425-31. PubMed ID: 7440705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary adenosine 3',5'-monophosphate, circulating amino-terminal PTH (1--34) and carboxyl-terminal PTH in hypoparathyroidism.
    Tomita A; Konagaya Y; Nakagawa H
    Contrib Nephrol; 1980; 22():59-67. PubMed ID: 6249542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of nephrogenous cyclic AMP, total urinary cyclic AMP and the renal tubular maximum reabsorptive capacity for phosphate in the diagnosis of primary hyperparathyroidism.
    Alston WC; Allen KR; Tovey JE
    Clin Endocrinol (Oxf); 1980 Jul; 13(1):17-25. PubMed ID: 6254697
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism.
    Bell NH; Avery S; Sinha T; Clark CM; Allen DO; Johnston C
    J Clin Invest; 1972 Apr; 51(4):816-23. PubMed ID: 4335445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
    Bikle DD; Herman RH
    J Clin Endocrinol Metab; 1983 Jan; 56(1):11-7. PubMed ID: 6292254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of adenosine 3',5'-monophosphate excretion and an oral calcium tolerance test in the diagnosis of mild primary hyperparathyroidism.
    Madvig P; Young G; Marcus R
    J Clin Endocrinol Metab; 1984 Mar; 58(3):480-7. PubMed ID: 6319454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ionized calcium, nephrogenous and total urinary cyclic AMP and urinary phosphate in normal subjects.
    Thode J; Holmegaard SN; Siggaard-Andersen O
    Scand J Clin Lab Invest; 1984 Apr; 44(2):111-8. PubMed ID: 6326252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of urinary cyclic AMP and phosphate to parathyroid extract in patients with parathyroid disorders.
    Aida M; Hurukawa Y; Miura K; Mihara A; Kato K
    Tohoku J Exp Med; 1975 Apr; 115(4):319-25. PubMed ID: 167473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical changes before and during oral calcium tolerance test in calcium stone formers.
    Kitamura T; Hirano Y; Ueda D; Aso Y
    Urol Res; 1988; 16(3):149-55. PubMed ID: 2842910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cyclic adenosine monophosphate: an accurate index of parathyroid function.
    Drezner MK; Neelon FA; Curtis HB; Lebovitz HE
    Metabolism; 1976 Oct; 25(10):1103-12. PubMed ID: 184364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary cyclic AMP:creatinine ratio and nephrogenous cyclic AMP as indicators parathyroid functional status.
    Stuart CA; Prochnow PA
    Endocr Res; 1986; 12(1):49-67. PubMed ID: 3009173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenous cyclic AMP and plasma parathyroid hormone in hypercalcaemia: the influence of renal function.
    Bill G; Jacquet AF; Burckhardt P
    Eur J Clin Invest; 1984 Jun; 14(3):227-32. PubMed ID: 6088250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in nephrogenous cyclic AMP excretion and plasma cyclic AMP following treatment of hyperthyroidism.
    Naafs MA; van der Velden PC; Fischer HR; Koorevaar G; van Duin S; Hackeng WH; Schopman W; Silberbusch J
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):477-81. PubMed ID: 6206676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired production and decreased urinary excretion of adenosine 3',5'-monophosphate in primary hyperparathyroidism with vitamin D deficiency.
    Rubinger D; Friedlaender MM; Silver J; Wald H; Shumart T; Popovtzer MM
    Miner Electrolyte Metab; 1988; 14(5):283-7. PubMed ID: 2845240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal threshold phosphate concentration (TmPO4/GFR).
    Kruse K; Kracht U; Göpfert G
    Arch Dis Child; 1982 Mar; 57(3):217-23. PubMed ID: 6280622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
    Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
    Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.